BMC Molecular Biology · 2019 · 28 citations · 29 references
Life SciencesCell BiologyMolecular BiologyGene ExpressionSignal TransductionTranscriptomicsCardiac PhysiologyCardiovascular PathologyCardiovascular PathophysiologyFibrosisMicrorna BiologyMicrorna-mediated RegulationAnnexin V AssaysCell Proliferation IndicesDual-luciferase AssaysLuciferase Reporter AssaysLuciferase ReportersPhenotypic AssaysWestern Blot AnalysisWestern Blotting
BACKGROUND: The current study aimed to investigate the effects of miR-32-5p on cardiac fibroblasts (CFs) that were induced with high levels of glucose; we also aimed to identify the potential mechanisms involved in the regulation of DUSP1 expression. METHODS: Human CFs were transfected with a miR-32-5p inhibitor or mimic and were treated with a normal concentration or a high concentration of glucose. Flow cytometry analysis was performed to identify cardiac fibroblasts by examining vimentin, fibronectin (FN) and α-actin expression in human CFs. qRT-PCR and western blot assays were performed to confirm the expression of miR-32-5p, DUSP1 and cardiac fibrosis relevant proteins. The proliferation of CFs was assessed by using MTT assay. An immunocytofluorescent staining assay was performed to determine the protein level of α-SMA and to investigate the degree of phenotypic changes in human CFs. The specific relationship between miR-32-5p and DUSP1 was investigated by a dual luciferase reporter assay. Cell apoptosis rates were measured with flow cytometry and the annexin V-FITC and propidine iodide (PI) staining method. RESULTS: A luciferase reporter assay indicated that miR-32-5p could directly target DUSP1. High glucose levels resulted in the overexpression of miR-32-5p, which downregulated DUSP1 expression. Both the upregulation of miR-32-5p and the downregulation of DUSP1 promoted cell apoptosis, proliferation and phenotypic changes in human CFs. CONCLUSIONS: All findings in this study provide further evidence for the positive effects of miR-32-5p on cell proliferation and the phenotypic changes in CFs by inhibiting DUSP1 expression, and reveal that miR-32-5p could serve as prognostic diagnostic target for cardiac fibrosis.
29
Diastolic Stiffness of the Failing Diabetic Heart
Loek van Heerebeek, Nazha Hamdani, M. Louis Handoko et al. · Circulation · 2007 · 731 citations · Full text
Medicine, Cardiology, Endocrinology +16
Indroneal Banerjee, John W. Fuseler, Robert L. Price et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2007 · 627 citations
Scot J. Matkovich, Wei Wang, Yizheng Tu et al. · Circulation Research · 2009 · 382 citations · Full text